0B68 McCauley, Jerry - Thomas Jefferson University - Thomas Jefferson University
jxm228

Jerry McCauley, MD, MPH, FACP

Contact Dr. McCauley

833 Chestnut Street
Suite 700
Philadelphia, PA 19107

(215) 955-9735
(215) 503-4953 fax

Most Recent Peer-reviewed Publications

  1. Cancer risk with alemtuzumab following kidney transplantation
  2. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: Statins not associated with improved patient or graft survival
  3. Kidney after nonrenal transplantation-the impact of alemtuzumab induction
  4. Neutrophilic tubulitis as a marker for urinary tract infection in renal allograft biopsies with C4d deposition
  5. Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-Year follow-up
  6. Kidney transplantation in elderly people: The influence of recipient comorbidity and living kidney donors
  7. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion
  8. Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short [5]
  9. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy
  10. Transplantation: polyomavirus nephropathy and the risk of specific immunosuppression regimens.
  11. Acute changes in renal function after laparoscopic gastric surgery for morbid obesity
  12. Steroid-free lymphocyte depletion protocols: The potential for partial tolerance?
  13. Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or campath and laparoscopy in living donor renal transplantation
  14. Comorbid conditions in kidney transplantation: Association with graft and patient survival
  15. Reversal of acute cellular rejection after renal transplantation with Campath-1H
  16. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: A single canter preliminary experience
  17. Drug therapy in transplant recipients: Special considerations in the elderly with comorbid conditions
  18. Labetalol-induced hyperkalemia in renal transplant recipients
  19. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients
  20. Evaluation of renal function in transplant patients on tacrolimus therapy
0